Physician profile
Meet Patel
NPI 1679849863
$35,918.50
in general payments reported to CMS, 2019-2025
20 companies · $6,534 in 2025
The $6,534 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $257 · 2021: $914 · 2022: $2,838 · 2023: $3,020 · 2024: $3,120 · 2025: $6,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,992 · Consulting Fee: $4,688 · Travel and Lodging: $2,994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,991.67 |
| Consulting Fee | $4,687.50 |
| Travel and Lodging | $2,993.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24,111.73 | 2019-2025 | Farapulse, Watchman Access System, Watchman Flx |
| Abbott Laboratories | $5,786.26 | 2019-2025 | Aveir |
| Medtronic Vascular, INC. | $1,752.54 | 2019-2020 | |
| Medtronic, INC. | $1,517.27 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Affera Mapping System |
| Biosense Webster, INC. | $1,114.99 | 2021-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $498.63 | 2020-2025 | Lifevest |
| Atricure, INC. | $376.37 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $288.32 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $136.94 | 2021-2023 | |
| Pfizer INC. | $126.52 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $56.66 | 2021-2022 | |
| Amgen INC. | $34.08 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $21.81 | 2022 | |
| Angiodynamics, INC. | $19.24 | 2025 | Angiovac |
| Cordis US Corp. | $18.61 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $16.56 | 2021 | |
| Lundbeck LLC | $13.10 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.00 | 2023 | Quviviq |
| Sanofi-Aventis U.S. LLC | $12.77 | 2021 | |
| Elutia, INC. | $3.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meet Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.